SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company: Aclaris Therapeutics, Inc.
Filed: December 19, 2019
Accession Number: 0000921895-19-003037

View Document ↗ View on SEC.gov ↗